More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Entrepreneur Magazine, Equities, and Daily Mom Include MJNA Portfolio Companies in Their Cannabis Industry Coverage

Entrepreneur Magazine, Equities, and Daily Mom Include MJNA Portfolio Companies in Their Cannabis Industry Coverage

by adminAdrianRamirez | Nov 21, 2018 | HempMeds, Kannaway, Media Coverage

Cannabis events, top CBD products for moms, and investing in the cannabis industry top Medical Marijuana, Inc.’s headlines this week. Medical Marijuana, Inc. and our family of companies continue to be leaders in the cannabis industry, as demonstrated by the inclusion...
Medical Marijuana, Inc. Subsidiary HempMeds® Launches New 2 oz. Green Label Liquid RSHO™ and 2 oz. Gold Label Liquid RSHO™

Medical Marijuana, Inc. Subsidiary HempMeds® Launches New 2 oz. Green Label Liquid RSHO™ and 2 oz. Gold Label Liquid RSHO™

by adminAdrianRamirez | Nov 19, 2018 | HempMeds

SAN DIEGO, Nov. 19, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary HempMeds® announced today the release of two new liquid hemp products: Real Scientific Hemp Oil™ (RSHO™) Green Label...
Medical Marijuana, Inc. Subsidiary HempMeds® to Exhibit at 2018 Marijuana Business Conference in Las Vegas

Medical Marijuana, Inc. Subsidiary HempMeds® to Exhibit at 2018 Marijuana Business Conference in Las Vegas

by adminAdrianRamirez | Nov 8, 2018 | HempMeds, Press Releases

SAN DIEGO, Nov. 8, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that subsidiary HempMeds® will exhibit its line of award-winning cannabidiol (CBD) hemp oil products at...
Medical Marijuana, Inc. Subsidiary HempMeds® Exhibits at SupplySide West 2018

Medical Marijuana, Inc. Subsidiary HempMeds® Exhibits at SupplySide West 2018

by adminAdrianRamirez | Nov 7, 2018 | HempMeds, Press Releases

SAN DIEGO, Nov. 7, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® will be exhibiting its line of cannabidiol (CBD) hemp oil products at SupplySide West,...
Yahoo Finance, Benzinga, and Green Market Report Among Medical Marijuana, Inc.’s Media Hits This Week

Yahoo Finance, Benzinga, and Green Market Report Among Medical Marijuana, Inc.’s Media Hits This Week

by adminAdrianRamirez | Nov 2, 2018 | HempMeds, HempMeds Mexico, Media Coverage

Interviews with our CEO, cannabis legalization on our northern and southern borders, and the benefits of CBD are among Medical Marijuana, Inc.’s top stories this week. Once again, Medical Marijuana, Inc. and our family of companies have made headlines around the...
The Washington Post, Men’s Health, MSN, and More Feature Medical Marijuana, Inc. Family of Companies

The Washington Post, Men’s Health, MSN, and More Feature Medical Marijuana, Inc. Family of Companies

by adminAdrianRamirez | Oct 26, 2018 | Axim Biotechnologies, HempMeds, Media Coverage

The Launch of Real Scientific® in Canada, CBD for Athletes, and clinical trials for MedChew RX® among the news from Medical Marijuana, Inc. this past week. As the CBD industry continues to grow, adding new markets and expanding CBD infused-products into existing...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.